Taurine-induced attenuation of MPP+ neurotoxicity in vitro: A possible role for the GABA(A) subclass of GABA receptors

Journal of Neurochemistry

Volumn 74, Issue 5, 2000, Pages 2087-2093

  O'Byrne, Muriel B ^a,b   Tipton, Keith F ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Dopamine; GABA receptors; MPP+ (1 methyl 4 phenylpyridinium); Neuroprotection; Neurotoxicity; Taurine

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 4 AMINOBUTYRIC ACID A RECEPTOR; TAURINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DRUG MECHANISM; GABAERGIC SYSTEM; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; BICUCULLINE; DRUG COMBINATIONS; FEMALE; GABA AGONISTS; GABA ANTAGONISTS; LIGANDS; MUSCIMOL; NEUROTOXINS; RATS; RATS, WISTAR; RECEPTORS, GABA-A; TAURINE;

ANIMALIA;

EID: 0034007740     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0742087.x     Document Type: Article

References (38)

1. Bates T. E., Heles S. J. R., Davies S. E. C., Boakye P., and Clark J. B. (1995) The effects of 1-methyl-4-phenyl-pyridinium on isolated rat brain mitochondria: evidence for a primary involvement of energy depletion. J. Neurochem. 63, 640-648.
2. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., and Kopin I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546-4550.
3. Chahine R. and Feng J. (1998) Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart. Arzneimittelforsch 48, 360-364.
4. Cunningham C., Tipton K. F., and Dixon H. B. F. (1998) Conversion of taurine into N-chlorotaurine (taurine chloramine) and sulfoacetaldehyde in response to oxidative stress. Biochem. J. 330, 939-945.
5. +. FEBS Lett. 198, 99-102.
6. Guidotti A., Badiani G., and Pepeu G. (1972) Taurine distribution in cat brain. J. Neurochem. 19, 431-435.
7. Haas H. L. and Hosli L. (1973) The depression of brain stem neurons by taurine and its interaction with strychnine and bicuculline. Brain Res. 52, 399-402.
8. Herranz A. S., Sous J. M., Herreras O., Menendez N., Ambrosio E., Orensanz L. M., and Martin del Rio R. (1990) The epileptogenic action of the taurine analogue guanidinoethane sulphonate may be caused by a blockade of GABA receptors. J. Neurosci. Res. 26, 98-104.
9. Huxtable R. J. (1981) Insights on function: metabolism and pharmacology of taurine in the brain, in The Role of Peptides and Amino Acids as Neurotransmitters (Lombardini J. B. and Kenny A., eds), pp. 53-97. Liss, New York.
10. Huxtable R. J. (1989) Taurine in the central nervous system and the mammalian actions of taurine. Prog. Neurobiol. 32, 471-533.
11. Huxtable R. J. (1992) Physiological actions of taurine. Physiol. Rev. 72, 101-163.
12. Irving C. S., Hammer B. E., Danyluk S. S., and Klein P. D. (1982) Taurine in Nutrition and Neurology (Huxtable R. J. and Pasantes-Morales H., eds), pp. 5-17. Plenum Press, New York.
13. Jenkins L. W., Becher D. P., and Coburn T. H. (1984) A quantitative analysis of glial swelling and ischemic neuronal injury following incomplete cerebral ischemia, in Recent Progress in the Study and Therapy of Brain Edema (Go T. and Baethmann A., eds), pp. 523-537. Plenum Press, New York.
14. Kass G. E., Wright J. M., Nicotera P., and Orrenius S. (1988) The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium. Arch. Biochem. Biophys. 260, 789-797.
15. Kollegger H., McBean G. J., and Tipton K. F. (1993) Reduction of striatal NMDA toxicity by inhibition of nitric oxide synthase. Biochem. Pharmacol. 45, 260-264.
16. Kontro P., Korpi E. R., and Oja S. S. (1990) Taurine: Functional Neurochemistry, Physiology and Cardiology (Pasantes-Morales H., Martin D. L., Shain W., and Martin del Rio R., eds), pp. 83-94. Wiley-Liss, New York.
17. Lombardini J. B. (1985) Effects of taurine on calcium ion uptake and protein phosphorylation in rat retinal membrane preparations. J. Neurochem. 45, 268-275.
18. 2+ uptake in synaptosomal and mitochondrial subcellular fractions of rat retina. J. Neurochem. 51, 200-205.
19. Magnusson K. R., Koerner J. F., Larson A. A., Smullin D. H., Skilling S. R., and Beitz A. J. (1991) NMDA-, kainate- and quisqualate-stimulated release of taurine from electrophysiologically monitored rat hippocampal slices. Brain Res. 549, 1-8.
20. Marangolo M., Zisterer D., Williams D. C., Tipton K. F., and Della-Corte L. (1997) Different specificities for taurine analogues and their target sites in brain, in Neurochemistry: Cellular, Molecular and Clinical Aspects (Teelken A. and Korf J., eds), pp. 959-962. Plenum Press, New York.
21. Markwell M. A. K., Haas S. M., Bieber L., and Tolbert N. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206-210.
22. Martin del Rio R. F., Herranz A. S., Herreras O., Menendez N., and Solis J. M. (1990) Possible osmoregulatory role of taurine in the cellular swelling evoked by weak organic acids in the rat hippocampus, in Taurine: Functional Neurochemistry, Physiology and Cardiology, Vol. 351 (Pasantes-Morales H., Martin D. L., Shain W., and del Rio R. M., eds), pp. 357-368. Wiley-Liss, New York.
23. Matsuda T., Takuma K., Kishida Y., Azuma J., and Baba A. (1996) Protective effect of taurine against reperfusion injury in cultured rat astrocytes. Adv. Exp. Med. Biol. 403, 491-497.
24. McBean G. J. (1990) Intrastriatal injection of DL-α-aminoadipate reduces kainate toxicity in vitro. Neuroscience 34, 255-234.
25. McBean G. J., Doorty K. B., Tipton K. F., and Kollegger H. (1995) Alterations in the glial cell metabolism of glutamate by kainate and N-methyl-D-aspartate. Toxicon 33, 569-576.
26. +. Neurosci. Lett. 65, 321-325.
27. + as studied in a tissue slice system. Biochem. Soc. Trans. 24, 62S.
28. O'Byrne M. B., Tipton K. F., McBean G. J., and Kollegger H. (1997) Assessment of neurotoxicity and "neuroprotection." J. Neural Trans. 50 (Suppl.), 153-164.
29. Okamoto K., Kimura H., and Sakai Y. (1983) Taurine-induced increase of the C1-conductance of cerebellar Purkinje cell dendrites in vitro. Brain Res. 259, 319-323.
30. 2+ uptake and respiration rate in rat liver mitochondria. Adv. Exp. Biol. Med. 403, 117-124.
31. Pazdernik T. L., Wade J. V., Nelson S. R., and Samson F. E. (1990) Is taurine involved in cerebral osmoregulation? in Taurine: Functional Neurochemistry, Physiology and Cardiology (Pasantes-Morales H., Martin D. L., Shain W., and del Rio R. M., eds), pp. 377-384. Wiley-Liss, New York.
32. 35S]-t-butylbicyclophosphorothionate (TBPS) to rat brain synaptic membranes. Neuropharmacology 34, 1607-1613.
33. +. Biochem. Biophys. Res. Commun. 189, 4752-4757.
34. Raschke P., Massoudy P., and Becker B. F. (1995) Taurine protects the heart from neutrophil-induced reperfusion injury. Free Radic. Biol. Med. 19, 461-471.
35. Rebel G., Petegniel V., Lieu P. L., Gupta R. C., Guerin P., and Bourguignon J. (1994) Taurine in Health and Disease (Huxtable R. and Michalk D. V., eds), pp. 225-233. Plenum Press, New York.
36. Schurr A., Tseng M. T., West C. A., and Rigor B. M. (1987) Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study. Life Sci. 40, 2059-2066.
37. Tipton K. F. and Singer T. P. (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61, 1191-1206.
38. Torp R., Andine P., Hagberg H., Karagulle T., Blackstad T. W., and Ottersen O. P. (1991) Cellular and subcellular redistribution of glutamate-, glutamine-, and taurine-like immunoreactivities during forebrain ischemia: a semiquantitative electron microscopic study in rat hippocampus. Neuroscience 41, 433-447.